UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas

Journal of clinical oncology, 2006-03, Vol.24 (9), p.1376-1382

2006

Link zum Volltext

Verfügbarkeit prüfen

Rituximab Improves the Efficacy of High-Dose Chemotherapy With Autograft for High-Risk Follicular and Diffuse Large B-Cell Lymphoma: A Multicenter Gruppo Italiano Terapie Innnovative nei Linfomi Survey

Journal of clinical oncology, 2008-07, Vol.26 (19), p.3166-3175

2008

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic Cells

Journal of clinical oncology, 1999-01, Vol.17 (1), p.208-215

1999

Link zum Volltext

Verfügbarkeit prüfen

PCR-Detectable Nonneoplastic Bcl-2/IgH Rearrangements Are Common in Normal Subjects and Cancer Patients at Diagnosis but Rare in Subjects Treated With Chemotherapy

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1398-1403

2003

Link zum Volltext

Verfügbarkeit prüfen

Syringotropic Mycosis Fungoides: A Rare Variant of the Disease With Peculiar Clinicopathologic Features

The American journal of surgical pathology, 2011, Vol.35 (1), p.100-109

2011

Link zum Volltext

Verfügbarkeit prüfen

Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma

Haematologica (Roma), 2001-04, Vol.86 (4), p.399

2001

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

The New England journal of medicine, 1997-05, Vol.336 (18), p.1290-1298

1997

Link zum Volltext

Verfügbarkeit prüfen

Tattoo-associated Pseudolymphomatous Reaction and its Successful Treatment with Hydroxychloroquine

Acta dermato-venereologica, 2009, Vol.89 (3), p.327-328

2009

Link zum Volltext

Verfügbarkeit prüfen

Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS)

EJD. European journal of dermatology, 2011-07, Vol.21 (4), p.624-625

2011

Link zum Volltext

Verfügbarkeit prüfen

Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients

Blood, 1999-08, Vol.94 (4), p.1248-1253

1999

Link zum Volltext

Verfügbarkeit prüfen

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma : evidence for a role of both chemotherapy and rituximab infusion

Blood, 2000-08, Vol.96 (3), p.864-869

2000

Link zum Volltext

Verfügbarkeit prüfen

C-reactive protein and β-2 microglobulin produce a simple and powerful myeloma staging system

Blood, 1992-08, Vol.80 (3), p.733-737

1992

Link zum Volltext

Verfügbarkeit prüfen

Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting

Blood, 1997-01, Vol.89 (2), p.724-731

1997

Link zum Volltext

Verfügbarkeit prüfen

Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma

Haematologica (Roma), 2002-08, Vol.87 (8), p.846

2002

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Sequential Chemoradiotherapy in Multiple Myeloma: Residual Tumor Cells Are Detectable in Bone Marrow and Peripheral Blood Cell Harvests and After Autografting

Blood, 1995-03, Vol.85 (6), p.1596-1602

1995

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis, prognosis, and standard treatment of multiple myeloma

Hematology/oncology clinics of North America, 1997-02, Vol.11 (1), p.111

1997

Link zum Volltext

Verfügbarkeit prüfen

Severe and long‐lasting disruption of T‐cell receptor diversity in human myeloma after high‐dose chemotherapy and autologous peripheral blood progenitor cell infusion

British journal of haematology, 2001-06, Vol.113 (4), p.1051-1059

2001

Link zum Volltext

Verfügbarkeit prüfen

Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cμ sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas

The Journal of experimental medicine, 1993-09, Vol.178 (3), p.1091-1096

1993

Link zum Volltext

Verfügbarkeit prüfen

Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: Evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3

Cancer, 2003-09, Vol.98 (5), p.983-992

2003

Link zum Volltext

Verfügbarkeit prüfen

Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy

The New England journal of medicine, 1990-05, Vol.322 (20), p.1430-1434

1990

Link zum Volltext

Verfügbarkeit prüfen

Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction

Haematologica (Roma), 2000-09, Vol.85 (9), p.978

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(92)

Sprache

Englisch
(92)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Medical Sciences
(90)
Humans
(89)
Life Sciences & Biomedicine
(70)
Science & Technology
(70)
Middle Aged
(52)
Female
(48)
Hematology
(46)
Male
(46)
Adult
(37)
Aged
(36)
Hematologic And Hematopoietic Diseases
(32)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(28)
Pharmacology. Drug Treatments
(28)
Antineoplastic Agents
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Oncology
(23)
Prognosis
(21)
Immunodeficiencies. Immunoglobulinopathies
(18)
Immunoglobulinopathies
(18)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas

Rituximab Improves the Efficacy of High-Dose Chemotherapy With Autograft for High-Risk Follicular and Diffuse Large B-Cell Lymphoma: A Multicenter Gruppo Italiano Terapie Innnovative nei Linfomi Survey

Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic Cells

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

PCR-Detectable Nonneoplastic Bcl-2/IgH Rearrangements Are Common in Normal Subjects and Cancer Patients at Diagnosis but Rare in Subjects Treated With Chemotherapy

Syringotropic Mycosis Fungoides: A Rare Variant of the Disease With Peculiar Clinicopathologic Features

Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

Tattoo-associated Pseudolymphomatous Reaction and its Successful Treatment with Hydroxychloroquine

Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS)

Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma : evidence for a role of both chemotherapy and rituximab infusion

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: A multicenter study of the Intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence

C-reactive protein and β-2 microglobulin produce a simple and powerful myeloma staging system

Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting

Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma

High-Dose Sequential Chemoradiotherapy in Multiple Myeloma: Residual Tumor Cells Are Detectable in Bone Marrow and Peripheral Blood Cell Harvests and After Autografting

Diagnosis, prognosis, and standard treatment of multiple myeloma

Severe and long‐lasting disruption of T‐cell receptor diversity in human myeloma after high‐dose chemotherapy and autologous peripheral blood progenitor cell infusion

Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cμ sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas

Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: Evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3

Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy

Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction

Aktive Filter

Suchergebnisse filtern